September 23, 2024
Pennsylvania’s health care providers are continuing to monitor trends in drug overdoses and illegal drug use across the commonwealth.
While prescription opioids and heroin have made headlines, providers are seeing more patients using fentanyl and stimulants like cocaine and methamphetamine, a panel of experts testified before state lawmakers today.
This morning, the House Republican Policy Committee hosted a hearing focused on Pennsylvania’s drug crisis, the impact of fentanyl and xylazine, and steps to support treatment and recovery. The hearing featured insights from the health care community, law enforcement, and drug treatment court officials.
“The drug overdose epidemic has evolved significantly over the last two decades,” Michael Lynch, MD, FACMT, UPMC Health Plan Quality and Substance Use Disorder Services and director of UPMC Medical Toxicology Telemedicine Bridge Clinic, said in prepared testimony.
Here are five things to know:
Luzerne County Assistant District Attorney Jessica Miraglia recounted her story, going through the Luzerne County Treatment Court as one of its first graduates to ultimately becoming the supervising prosecutor for the county’s treatment courts years later. “Giving me services and supporting me was all I needed,” she said.
HAP and Pennsylvania hospitals are focused on efforts that support access to care and long-term recovery across the commonwealth. This includes ensuring investment in our behavioral health care system to meet the growing demand for this care.
Today’s hearing is available to watch online.
Tags: Public Health | Behavioral Health
Click on topic below for category-specific news articles.
Related Links